Premium
Short and medium term outcomes after rollerball endometrial ablation for menorrhagia
Author(s) -
Fraser Ian S,
Mahmoud Farouk,
Yezerski Sol,
Angsuwathana Surasak
Publication year - 1993
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1993.tb137573.x
Subject(s) - medicine , endometrial ablation , dysfunctional uterine bleeding , diathermy , surgery , hysterectomy , ablation , uterine perforation , endometrium , population , obstetrics , research methodology , environmental health , family planning
Objective To review prospectively the intraoperative, short and medium term outcomes of patients treated by rollerball endometrial ablation during the learning curve for this relatively new procedure. Patients and techniques Seventy‐seven women with menorrhagia (71 with dysfunctional bleeding; six with additional small intramural myomas) underwent hysteroscopic rollerball endometrial ablation by coagulation diathermy during 1.5% glycine irrigation, after a two‐month period of hormonal suppression. Operative and short‐term effects These were recorded at operation and six‐week follow‐up. No serious short‐term complications were recorded. Objective measurement of intraoperative blood loss was always less than 20 mL. One woman experienced uterine perforation with a narrow cervical dilator which did not interfere with the ablation, and two patients had mild postoperative uterine infections. One patient experienced persistent postoperative pain. Medium‐term outcome This was recorded at each visit, or by telephone, and confirmed by questionnaire at one year. Twenty‐five per cent achieved complete amenorrhoea, 29% staining only, 30% light periods, 10% “normal” or erratic periods and 6% were unchanged. Five patients underwent a second ablation, and three of these later underwent hysterectomy. Measured menstrual blood loss fell from 104 ±19 mL (mean ± standard error of mean) to 1.7 ±1.1 mL at six months in 18 women. Other menstrual symptoms were also often dramatically reduced. Of those women with dysmenorrhoea, 33% were cured and 43% markedly improved; of those with midcycle pain, 28% were cured and 53% markedly improved; of those with significant premenstrual symptoms, 13% were cured, 47% markedly improved, 11% unchanged, and 6% were worse. Conclusion This new procedure is a safe and effective treatment for menorrhagia caused by dysfunctional uterine bleeding, with impressive ancillary benefits for dysmenorrhoea, midcycle pain and premenstrual tension. It is often called minimally invasive surgery, but it must be recognised that it is not minor surgery.